Top

European Child & Adolescent Psychiatry

Published in:

01-09-2016 | Letter to the Editor

The evidence base of methylphenidate for children and adolescents with attention-deficit hyperactivity disorder is in fact flawed

Authors: Ole Jakob Storebø, Erik Simonsen, Christian Gluud

Published in: European Child & Adolescent Psychiatry | Issue 9/2016

Excerpt

Dear Editors, …

Storebø OJ, Ramstad E, Krogh HB, Nilausen TD, Skoog M, Holmskov M, Rosendal S, Groth C, Magnusson FL, Moreira Maia CR, Gillies D, Buch Rasmussen K, Gauci D, Zwi M, Kirubakaran R, Forsbøl B, Simonsen E, Gluud C (2015) Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database Syst Rev. doi:10.1002/14651858.CD009885.pub2 PubMed

Hoekstra Pieter J, Buitelaar Jan K (2016) Is the evidence base of methylphenidate for children and adolescents with attention–deficit/hyperactivity disorder flawed? Eur Child Adolesc Psychiatry. doi:10.1007/s00787-016-0845-2

Higgins JPT, Green S (2011) The Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. In: The Cochrane Collaboration. Available from http://www.cochrane-handbook.org

Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L (2012) Industry sponsorship and research outcome. Cochrane Database Syst Rev, 12:MR000033

Bero L (2013) Why the Cochrane risk of bias tool should include funding source as a standard item [editorial]. Cochrane Database Syst Rev, 12. doi:10.1002/14651858.ED000075

Savović J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J et al (2012) Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Ann Intern Med 157(6):429–438CrossRefPubMed

Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG et al (2008) Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 336(7644):601–605CrossRefPubMedPubMedCentral

Moncrieff J, Wessely S, Hardy R (2004) Active placebos versus antidepressants for depression. Cochrane Database Syst Rev, Issue 1. Art. No.: CD003012. doi:10.1002/14651858.CD003012.pub2

Požgain I, Požgain Z, Degmečić D (2014) Placebo and nocebo effect: a mini review. Psychiatr Danub 26(2):100–107PubMed

10.

Mitsikostas DD, Mantonakis L, Chalarakis N (2014) Nocebo in clinical trials for depression: a meta-analysis. Psychiatry Res 215(1):82–86CrossRefPubMed

Title: The evidence base of methylphenidate for children and adolescents with attention-deficit hyperactivity disorder is in fact flawed
Authors: Ole Jakob Storebø
Erik Simonsen
Christian Gluud
Publication date: 01-09-2016
Publisher: Springer Berlin Heidelberg
Published in: European Child & Adolescent Psychiatry / Issue 9/2016
Print ISSN: 1018-8827
Electronic ISSN: 1435-165X
DOI: https://doi.org/10.1007/s00787-016-0855-0

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

The evidence base of methylphenidate for children and adolescents with attention-deficit hyperactivity disorder is in fact flawed

Excerpt

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 9/2016

Posttraumatic symptoms and cognitions in parents of children and adolescents with PTSD

Gray matter volumes in symptomatic and asymptomatic offspring of parents diagnosed with bipolar disorder

Diagnostic efficiency of the SDQ for parents to identify ADHD in the UK: a ROC analysis

Response to: The evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder is in fact flawed

Adolescent boys with autism spectrum disorder growing up: follow-up of self-reported sexual experience

Dual-task performance under acute stress in female adolescents with borderline personality disorder